Metformin was shown to upregulate AMPK signaling and thus downregulate HIF-1α, transforming growth factor-β (TGF-β) and interleukin 8 (IL-8) in co-culture of CAFs with human breast cancer lines and thus preventing tumor-stroma crosstalk (86). Here, HIF1A is linked to neoplasm.